98%
921
2 minutes
20
The aim of this study is to investigate the diagnostic efficiency of gastrin, pepsinogen, proinflammatory cytokines (TNF-α, IL-6), and oxidative stress biomarkers in horses with equine gastric ulcer syndrome (EGUS). Thirty horses diagnosed with gastroscopic EGUS and 15 clinically healthy horses were selected for this study. The serum levels of gastrin, pepsinogen showed nonsignificant changes in horses with EGUS when compared with healthy horses. The serum levels of TNF-α, IL-6 revealed a significant increase in horses with EGUS when compared with healthy ones. Oxidative stress is evident in horses with EGUS in comparison with healthy horses as detected by higher levels of malondialdehyde (MDA) and decreased serum levels of total antioxidant capacity (TAC), Superoxide dismutase (SOD), glutathione (GSH), and nitric oxide (NO). MDA and TNF-α showed better sensitivity and specificity than IL-6 in distinguishing horses with EGUS from control horses. Conclusively, examination of serum gastrin and pepsinogen levels had a limited value in diagnosis of EGUS in horses under investigation. Moreover, this study showed that oxidative stress is evident in horses with EGUS. Higher levels of TNF-α and IL-6 indicate their role in EGUS pathogenesis in horses. Finally, MDA, TNF-α, and IL-6 could be used as biological markers for preliminary screening of horses with EGUS. Gastroscopy still accredited as the "gold standard" for diagnosis EGUS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jevs.2019.102853 | DOI Listing |
Equine Vet J
September 2025
School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, Glasgow, UK.
Background: It is unknown whether the high prevalence of Equine Squamous (ESGD) and Equine Glandular (EGGD) Gastric Disease in extensively grazed Icelandic horses in the autumn/winter is seasonally driven.
Objectives: To determine the prevalence of, and risk factors for, gastroscopically significant ESGD (ESGD:score of ≥2/4); gastroscopically severe ESGD (ESGD:score of ≥3/4) and gastroscopically significant EGGD (EGGD:score of ≥1/2) in extensively pasture-managed Icelandic horses at four timepoints.
Study Design: Prospective longitudinal cohort.
J Equine Vet Sci
October 2025
Equine Medicine and Surgery Research Line (LIMCE), CENTAURO Research Group, School of Veterinary Medicine, Faculty of Agricultural Sciences, University of Antioquia, Medellin 050010, Colombia.
Background: Information regarding Survivin protein expression in the gastric mucosa of equids is scarce. This protein has been associated with functions related to modulating apoptosis and promoting mitosis in epithelial cells and is considered part of gastric cytoprotection mechanisms in humans and mice, maintaining mucosal integrity and regulating cellular renewal.
Aims/objectives: This study aimed to determine the expression of cytoplasmic and nuclear Survivin in gastric mucosae of equids (horses, donkeys, and mules).
Animals (Basel)
July 2025
Department of Animal Medicine and Surgery, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, Espinardo, 30100 Murcia, Spain.
This study arises from the search for non-invasive diagnostic alternatives for equine gastric ulceration (EGUS), which is prevalent, clinically variable and only confirmed by gastroscopy. The aim is to quantify five salivary biomarkers (IL1-F5, PIP, CA VI, serotransferrin, albumin) under clinical conditions by validated assays and analyse their diagnostic value. Horses were grouped in No EGUS (neither clinical signs of EGUS nor gastric lesions), EGUS non-clinical (apparently no clinical signs of EGUS but with gastric lesions), and EGUS clinical (obvious clinical signs of EGUS and with gastric lesions).
View Article and Find Full Text PDFEquine Vet J
May 2025
Department of Clinical Science and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand.
Background: Phenylbutazone (PBZ) can potentially induce gastrointestinal ulceration, and early detection of PBZ-induced gastroenteropathy will be useful for the diagnosis, treatment, and prevention of PBZ toxicity.
Objectives: To identify putative proteins associated with equine gastric ulcer syndrome after clinical dose (4.4 mg/kg) administration of PBZ by proteomic study.
J Equine Vet Sci
June 2025
École Nationale Vétérinaire d'Alfort, CHUV-EQ, ACAP3, 1504, Route de l'Église, 14430, Goustranville, France.
Equine gastric ulceration syndrome (EGUS) is a common condition, affecting both glandular (EGGD) and squamous (ESGD) mucosa of the stomach. It has a high prevalence, particularly in racehorses and sport horses, causing clinical signs from poor performance to colic. Gastroscopy, the reference standard diagnostic method, is expensive, prompting the search for alternative tests.
View Article and Find Full Text PDF